Cardioxane is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Clinigen Healthcare Ltd. The primary component is Dexrazoxane Hydrochloride.
Product ID | 76310-002_5a881549-9d86-4ff7-b4ab-2cfb315f9af3 |
NDC | 76310-002 |
Product Type | Human Prescription Drug |
Proprietary Name | Cardioxane |
Generic Name | Dexrazoxane |
Dosage Form | Injection, Powder, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2017-07-28 |
Marketing Category | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE / UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
Labeler Name | Clinigen Healthcare Ltd |
Substance Name | DEXRAZOXANE HYDROCHLORIDE |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Cytoprotective Agent [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2017-07-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | Unapproved drug for use in drug shor |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-07-28 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
DEXRAZOXANE HYDROCHLORIDE | 500 mg/1 |
SPL SET ID: | 16966fee-364e-4c76-b6ad-065d41a611e4 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
76310-002 | Cardioxane | dexrazoxane |
0143-9247 | Dexrazoxane | Dexrazoxane |
0143-9248 | Dexrazoxane | Dexrazoxane |
55150-434 | DEXRAZOXANE | DEXRAZOXANE |
55150-437 | DEXRAZOXANE | DEXRAZOXANE |
67457-207 | Dexrazoxane Hydrochloride | dexrazoxane |
67457-208 | Dexrazoxane Hydrochloride | dexrazoxane |
0013-8717 | Zinecard | dexrazoxane |
0013-8727 | Zinecard | dexrazoxane |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CARDIOXANE 86969771 5561522 Live/Registered |
Clinigen Healthcare Limited 2016-04-08 |
CARDIOXANE 85885417 not registered Dead/Abandoned |
Clinigen Healthcare Limited 2013-03-25 |